Role of Gpnmb in atherosclerosis of female mice.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
17 09 2022
Historique:
received: 27 05 2022
accepted: 24 06 2022
pubmed: 10 7 2022
medline: 6 8 2022
entrez: 9 7 2022
Statut: ppublish

Résumé

Atherosclerosis has become prevalent not only in Western industrialized countries but all over the globe. Gpnmb, a transmembrane protein expressed by macrophages, has been detected in aortic lesions. We created an ApoE/Gpnmb-double knockout mouse using Crispr-Cas9 to examine the effect of Gpnmb deficiency on the development of atherosclerotic plaques. Feeding female mice a high cholesterol diet for 8 and 12 weeks, we detected an increased plaque size in aortic root sections of Gpnmb-deficient compared to control mice. However, the plaque area in whole thoracic and abdominal aorta was not different. Despite its strong expression in macrophages in aortic plaques, Gpnmb exerts only a minor effect on the growth of the atherosclerotic plaques in female mice. Future studies should examine plaque stability and include both sexes to elucidate the sex-specific function of Gpnmb in atherosclerosis.

Identifiants

pubmed: 35809343
pii: S0006-291X(22)00942-1
doi: 10.1016/j.bbrc.2022.06.082
pii:
doi:

Substances chimiques

Eye Proteins 0
Gpnmb protein, mouse 0
Membrane Glycoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-24

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Bernadette Nickl (B)

Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert Rössle Str. 10, 13125, Berlin, Germany.

Fatimunnisa Qadri (F)

Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert Rössle Str. 10, 13125, Berlin, Germany.

Michael Bader (M)

Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert Rössle Str. 10, 13125, Berlin, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany; Charité University Medicine, Charitéplatz 1, 10117, Berlin, Germany; University of Lübeck, Institute for Biology, Ratzeburger Allee 160, 23538, Lübeck, Germany. Electronic address: mbader@mdc-berlin.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH